Active Ingredient
Alcaftadine 0.25%
The following Structured Product Label (SPL) was submitted to the FDA by Allergan, Inc. for the product Lastacaft (NDC 0023-4291). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, when using this product, stop use and ask a doctor if, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Alcaftadine 0.25%
Antihistamine
Temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.
For external use only.
Do not use
■ if solution changes color or becomes cloudy.
■ if you are sensitive to any ingredient in this product.
■ to treat contact lens related irritation.
■ do not touch tip of container to any surface to avoid contamination.
■ remove contact lenses before use.
■ wait at least 10 minutes before reinserting contact lenses after use.
■ do not wear a contact lens if your eye is red.
you experience any of the following:
■ eye pain.
■ changes in vision.
■ increased redness of the eye.
■ itching that worsens or lasts for more than 72 hours.
If swallowed, get medical help or contact a Poison Control Center right away.
■ Only for use in the eye.
■ Store at 15°-25°C (59°-77°F).
benzalkonium chloride 0.005%, edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid.
LASTACAFT
Alcaftadine ophthalmic solution 0.25%
Antihistamine Eye Drops
120 DAY SUPPLY
2 bottles (0.17 fl oz (5 mL) each Sterile
LASTACAFT
Alcaftadine ophthalmic solution 0.25%
Antihistamine Eye Drops
60 DAY SUPPLY
0.17 fl oz (5 mL) Sterile
LASTACAFT
Alcaftadine ophthalmic solution 0.25%
Antihistamine Eye Drops
0.17 fl oz (5 mL) Sterile
* Please review the disclaimer below.